Experienced in Boils

Dr. Mezgebe Berhe

Infectious Disease | Internal Medicine
Baylor Scott & White Health
North Texas Infectious Diseases Consultants, P.A.
3409 Worth Street, Suite 710, 
Dallas, TX 
Offers Telehealth
33 Years of Experience
Experienced in Boils
Baylor Scott & White Health
North Texas Infectious Diseases Consultants, P.A.
3409 Worth Street, Suite 710, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mezgebe Berhe is an Infectious Disease specialist and an Internal Medicine provider in Dallas, Texas. Dr. Berhe has been practicing medicine for over 33 years and is rated as an Experienced provider by MediFind in the treatment of Boils. His top areas of expertise are Osteomyelitis, HIV/AIDS, Osteomyelitis in Children, and Myelitis.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Addis Ababa University, 1993.0
Residency
Internal Medicine, St Barnabas Hospital
Specialties
Infectious Disease
Internal Medicine
Licenses
Specialist in TX
Board Certifications
American Board Of Internal Medicine
Fellowships
Infectious Disease, Medical College of Virginia Hospitals
Infectious Diseases, Medical College of Virginia
Hospital Affiliations
Baylor Scott & White Heart & Vascular Hospital - Dallas
Baylor University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Primewell Health Services
  • HMO
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • POS
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

North Texas Infectious Diseases Consultants, P.A.
3409 Worth Street, Suite 710, Dallas, TX 75246
Call: 972-449-0540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3 Study of the Safety of Trogarzo® Administered as an Undiluted IV Push Over a Reduced Interval or as an Intramuscular Injection in Clinically Stable HIV-1 Infected Trogarzo® Experienced Patients and Healthy HIV-uninfected Volunteers
A Phase 3 Study of the Safety of Trogarzo® Administered as an Undiluted IV Push Over a Reduced Interval or as an Intramuscular Injection in Clinically Stable HIV-1 Infected Trogarzo® Experienced Patients and Healthy HIV-uninfected Volunteers
Enrollment Status: Completed
Publish Date: October 20, 2025
Intervention Type: Drug
Study Drug: Ibalizumab-uiyk
Study Phase: Phase 3
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
Enrollment Status: Terminated
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drugs: GSK3640254, ABC/3TC, FTC/TAF, Dolutegravir
Study Phase: Phase 2
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients With Severe COVID-19 Infection
A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients With Severe COVID-19 Infection
Enrollment Status: Completed
Publish Date: January 20, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase 3b Multi-center, Open Label, Single Arm, 52-week Study, Evaluating the Feasibility, Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using a Fixed Dose Combination of Dolutegravir Plus Lamivudine (DOVATO) as a First Line Regimen
A Phase 3b Multi-center, Open Label, Single Arm, 52-week Study, Evaluating the Feasibility, Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using a Fixed Dose Combination of Dolutegravir Plus Lamivudine (DOVATO) as a First Line Regimen
Enrollment Status: Completed
Publish Date: October 21, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase Placebo-Controlled, Sequential Single Dose Escalation Study of the Safety, Pharmacokinetics, and Antiretroviral Activity of IVTMB-365 in HIV-1 Infected Participants
A Phase Placebo-Controlled, Sequential Single Dose Escalation Study of the Safety, Pharmacokinetics, and Antiretroviral Activity of IVTMB-365 in HIV-1 Infected Participants
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Biological
Study Drug: TMB-365
Study Phase: Phase 1
View 5 Less Clinical Trials

19 Total Publications

Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study.
Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 04, 2025
View All 19 Publications
Similar Doctors
Experienced in Boils
Dr. Cedric W. Spak
Infectious Disease | Internal Medicine
Experienced in Boils
Dr. Cedric W. Spak
Infectious Disease | Internal Medicine

Texas Centers For Infectious Disease Associates

3410 Worth St, Ste 780, 
Dallas, TX 
 (0.1 miles away)
972-449-0540
Experience:
27+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Cedric Spak is an Infectious Disease specialist and an Internal Medicine provider in Dallas, Texas. Dr. Spak has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Boils. His top areas of expertise are Actinomycosis, Cytomegalic Inclusion Disease, Cytomegalovirus Infection, and Osteomyelitis.

Experienced in Boils
Dr. Bryan E. Youree
Infectious Disease | Internal Medicine
Experienced in Boils
Dr. Bryan E. Youree
Infectious Disease | Internal Medicine

Texas Centers For Infectious Disease Associates

3410 Worth St, Ste 780, 
Dallas, TX 
 (0.1 miles away)
972-449-0540
Experience:
27+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bryan Youree is an Infectious Disease specialist and an Internal Medicine provider in Dallas, Texas. Dr. Youree has been practicing medicine for over 27 years and is rated as an Advanced provider by MediFind in the treatment of Boils. His top areas of expertise are COVID-19, Sepsis, End-Stage Renal Disease (ESRD), Lymphangitis, and Gastrostomy.

Experienced in Boils
Dr. Devak G. Desai
Infectious Disease | Internal Medicine
Experienced in Boils
Dr. Devak G. Desai
Infectious Disease | Internal Medicine

ID Partners PA

350 Matlock Rd, Ste, Suite 201, 
Mansfield, TX 
 (26.0 miles away)
682-205-3501
Experience:
19+ years
Languages Spoken:
English
See accepted insurances

Devak Desai is an Infectious Disease specialist and an Internal Medicine provider in Mansfield, Texas. Dr. Desai has been practicing medicine for over 19 years and is rated as a Distinguished provider by MediFind in the treatment of Boils. His top areas of expertise are Sepsis, Lymphangitis, Osteomyelitis, and Methicillin-Resistant Staphylococcus Aureus (MRSA).

VIEW MORE BOILS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Berhe's expertise for a condition
ConditionClose
    • Distinguished
    • Osteomyelitis
      Dr. Berhe is
      Distinguished
      . Learn about Osteomyelitis.
      See more Osteomyelitis experts
    • Advanced
    • AIDS Dementia Complex
      Dr. Berhe is
      Advanced
      . Learn about AIDS Dementia Complex.
      See more AIDS Dementia Complex experts
    • AIDS Dysmorphic Syndrome
      Dr. Berhe is
      Advanced
      . Learn about AIDS Dysmorphic Syndrome.
      See more AIDS Dysmorphic Syndrome experts
    • Familial Chronic Mucocutaneous Candidiasis
      Dr. Berhe is
      Advanced
      . Learn about Familial Chronic Mucocutaneous Candidiasis.
      See more Familial Chronic Mucocutaneous Candidiasis experts
    • HIV/AIDS
      Dr. Berhe is
      Advanced
      . Learn about HIV/AIDS.
      See more HIV/AIDS experts
    • Myelitis
      Dr. Berhe is
      Advanced
      . Learn about Myelitis.
      See more Myelitis experts
    • Osteomyelitis in Children
      Dr. Berhe is
      Advanced
      . Learn about Osteomyelitis in Children.
      See more Osteomyelitis in Children experts
    • Experienced
    • Arachnoiditis
      Dr. Berhe is
      Experienced
      . Learn about Arachnoiditis.
      See more Arachnoiditis experts
    • Avian Influenza
      Dr. Berhe is
      Experienced
      . Learn about Avian Influenza.
      See more Avian Influenza experts
    • Boils
      Dr. Berhe is
      Experienced
      . Learn about Boils.
      See more Boils experts
    • Cellulitis
      Dr. Berhe is
      Experienced
      . Learn about Cellulitis.
      See more Cellulitis experts
    • Common Variable Immune Deficiency
      Dr. Berhe is
      Experienced
      . Learn about Common Variable Immune Deficiency.
      See more Common Variable Immune Deficiency experts
    • COVID-19
      Dr. Berhe is
      Experienced
      . Learn about COVID-19.
      See more COVID-19 experts
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.